PRECISION BIOSCIENCES INC — Director's Dealing 2025

Jul 8, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2025-07-03

Reporting Person: Kelly John Alexander (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-07-03	Common Stock	S	14827	$4.26	Disposed	73485	Direct

Footnotes

F1: The sales were effected pursuant to a Rule 10b5-1 plan adopted on January 17, 2025. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the settlement of 44,368 RSUs which vested on January 20, 2025. The settlement occurred on July 3, 2025, as approved by the Issuer's Compensation Committee. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.

F2: Includes 2,056 shares acquired under the Issuer's 2019 Employee Stock Purchase Plan at a weighted average price of $7.21.